NCT07476001 2026-03-17
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
Clinical Trials
1 trialsOTHER × Metastatic Castration-resistant Prostate Cancer × Gonadotropin-Releasing Hormone × Clear all